These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries. Tilz RR; Dagres N; Arbelo E; Blomström-Lundqvist C; Crijns HJ; Kirchhof P; Kautzner J; Temporelli PL; Laroche C; Roberts PR; Pehrson S; Lip GYH; Brugada J; Tavazzi L; Europace; 2020 Feb; 22(2):250-258. PubMed ID: 31768523 [TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure. Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes. Younis A; Tabaja C; Santangeli P; Nakagawa H; Sipko J; Madden R; Bouscher P; Taigen T; Higuchi K; Hayashi K; El Hajjar AH; Chamseddine F; Callahan T; Martin DO; Nakhla S; Kanj M; Sroubek J; Lee JZ; Saliba WI; Wazni OM; Hussein AA Circ Arrhythm Electrophysiol; 2024 Sep; 17(9):e012926. PubMed ID: 39193716 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O; Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423 [TBL] [Abstract][Full Text] [Related]
7. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study. Saksena S; Slee A; Saad M J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682 [TBL] [Abstract][Full Text] [Related]
8. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry. Kapłon-Cieślicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padrón A; Fucili A; Drożdż J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH; ESC Heart Fail; 2020 Oct; 7(5):2098-2112. PubMed ID: 32618139 [TBL] [Abstract][Full Text] [Related]
9. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction. Son MK; Park JJ; Lim NK; Kim WH; Choi DJ Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140 [TBL] [Abstract][Full Text] [Related]
10. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation. Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G Eur J Heart Fail; 2015 Jun; 17(6):570-82. PubMed ID: 25727992 [TBL] [Abstract][Full Text] [Related]
11. Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) Registry. Vassilikos VP; Pagourelias ED; Laroche C; Blomström-Lundqvist C; Kautzner J; Maggioni AP; Tavazzi L; Dagres N; Brugada J; Stühlinger M; Arbelo E; Europace; 2021 Jan; 23(1):49-58. PubMed ID: 33141150 [TBL] [Abstract][Full Text] [Related]
12. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide. Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617 [TBL] [Abstract][Full Text] [Related]
13. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043 [TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. Sartipy U; Dahlström U; Fu M; Lund LH JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registry. Eitel C; Ince H; Brachmann J; Kuck KH; Willems S; Gerds-Li JH; Tebbenjohanns J; Richardt G; Hochadel M; Senges J; Tilz RR Clin Res Cardiol; 2019 Jul; 108(7):815-823. PubMed ID: 30788620 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study. Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498 [TBL] [Abstract][Full Text] [Related]
17. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. Siller-Matula JM; Pecen L; Patti G; Lucerna M; Kirchhof P; Lesiak M; Huber K; Verheugt FWA; Lang IM; Renda G; Schnabel RB; Wachter R; Kotecha D; Sellal JM; Rohla M; Ricci F; De Caterina R; Int J Cardiol; 2018 Aug; 265():141-147. PubMed ID: 29706429 [TBL] [Abstract][Full Text] [Related]
18. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF). Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492 [TBL] [Abstract][Full Text] [Related]